The adoption of a Stockholder Rights Plan, also known as a 'poison pill', is a defensive strategy against hostile takeovers. While it can reassure investors that the board is taking steps to protect their interests, it may also be viewed as a deterrent to investment by some shareholders who prefer more open market policies. The short-term impact on CTRN's stock price could be neutral as the market digests the implications of the Rights Plan.